Postoperative development of sarcopenia is a strong predictor of a poor prognosis in patients with adenocarcinoma of the esophagogastric junction and upper gastric cancer
American Journal of Surgery Jul 19, 2018
Kudou K, et al. - In patients with adenocarcinoma of esophagogastric junction (AEG) and upper gastric cancer (UGC), researchers evaluated if postoperative development of sarcopenia could predict a poor prognosis. Findings revealed a correlation of postoperative development of sarcopenia with poor prognosis in these patients.
Methods
- Researchers assessed postoperative development of sarcopenia 6 months after surgery in patients with AEG and UGC who were judged as non-sarcopenic before surgery.
- Stratification of patients into the development group or non-development group was performed.
- The groups were analyzed in terms of clinicopathological factors and prognosis.
Results
- The development group displayed significantly poorer 5-year overall survival rates vs non-development group (68.0% vs 92.6%, P=0.0118).
- Postoperative development of sarcopenia was noted as an independent prognostic factor for poor overall survival in multivariate analyses (P=0.0237).
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries